Industry Collaborations Company Logo Cengiz A Tarhan Managing Director UCL Business PLC UCL Enterprise at UCL role of UCLB Why we collaborate Recent examples Summary Overview ID: 603786
Download Presentation The PPT/PDF document "IPR in Successful University" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
IPR in Successful University - Industry Collaborations
Company Logo
Cengiz
A
Tarhan
Managing Director
UCL Business PLC Slide2
UCL
Enterprise at UCL –
role of UCLB
Why we collaborate
Recent examples
Summary
OverviewSlide3
Established
over 180 years
ago
First university in England to
admit students of any race, class or religion, welcome women on equal terms
teach experimental science, modern European languages, Laws…
Today – over 4000 researchers and Ranked 5th in the QS World University rankings for 2014 and 20th
in the Academic Ranking of World Universities -
2014
(
3rd
in Europe)
Exceptional strength in
BioMedicine
UCL – London’s Global University
UCL – London’s Global UniversitySlide4
“UCL ranked the leading institution in the UK as a partner for industry in the biotechnology and pharmaceutical sectors”
May 2013
OverviewSlide5
Enterprise at UCL is evolvingSlide6
Why we collaborate with Industry
It
makes sense
Best universities and best companies do
Symbiotic relationship – should be two way
Helps achieve our mission to make IMPACT
But
;
Pick your partners well
Protect your reputation
Remain flexible on terms
Document the arrangement
Manage the relationshipSlide7
Direct
Studentships – beware of IP leakage
Consultancy – IP rights defined within agreement
Contract research – usually IP vested in company
Collaborative research – complex IP negotiation
Strategic partnerships – multiple programs
IndirectThrough UCL’s spin out companies
Through our partner hospitals
Examples of collaboration with Industry at UCL Slide8
Overvaluing
IP
Undervaluing
IP
Warranties and
indemnities
Access to Background IPLicensing versus assigningOwnership of Arising/Foreground
IP
Money –
costs/upfront/milestones/royalties
Termination – what happens to
IP
And more!
When IP is InvolvedSlide9
Eisai
– drug discovery alliance
Pfizer – collaboration on stem cell- based
technology
Novozymes
BioPharma – combining technology platformsCell Therapy Catapult – treatment for leukaemia
Novo Nordisk – mapping
diabetes
Takeda – tackling muscle disorders and muscular dystrophy
Recent examples of collaborative research at UCLSlide10
Most high tech displays and touchscreens are made of transparent conductive film which requires Indium Tin Oxide (ITO
)
Costs of processing ITO are high and screens tend to be brittle – not suitable for flexible displays.
Collaboration with
Linde
is based on developing a solution to use Single walled carbon nanotubes (SWCN) as an alternative.
Unlocking the potential of Carbon Nanotubes Slide11
Researchers at UCL identified a way of purifying the SWCN’s to make them useful for new generation flexible screens
.
Unlocking
the potential of
Carbon Nanotubes Slide12
Patent protection
secured
Licence to
Linde
Group in 2011
Linde
Nanomaterials formed in 2012 with manufacturing facility in San Marcos, CaliforniaSEER
e
-
Ink launched in
2013
Potential
highlighted in
Touch Display Research Inc., ITO-replacement report, May 2014) estimating non ITO-transparent conducting films market is likely to be worth $8.1billion by 2021
Unlocking
the potential of
Carbon Nanotubes Slide13
UCL
is committed to Enterprise to deliver
IMPACT
Engagement
with Industry is crucial
IPR
plays an important role It’s a relationship with ‘ups and downs’
Successful
relationship needs to be ‘managed’
Summary